Hemolysis pancreatic

Deficiency of vitamin E is characterized by low serum tocopherol levels and a positive hydrogen peroxide hemolysis test. This deficiency is believed to occur in patients with biliary, pancreatic, or intestinal disease that is characterized by excessive steatorrhea. Premature infants with a high intake of fatty acids exhibit a deficiency syndrome characterized by edema, anemia, and low tocopherol levels. This condition is reversed by giving vitamin E. 

Mechanism of Action An antioxidant that prevents oxidation of vitamins A and C, protects fatty acids from aff ack by free radicals, and protects RBCs from hemolysis by oxidizing agents. Therapeutic Effect Prevents and treats vitamin E deficiency. Pharmacokinetics Variably absorbed from the GI tract (requires bile salts, dietary fat, and normal pancreatic function). Primarily concentrated in adipose tissue. Metabolized in the liver. Primarily eliminated by biliary system. 

Crossover studies have shown that mesalazine has about a 10-fold lower potential than sulfasalazine for inducing allergic reactions or causing intolerance. Adverse effects with all aminosalicylates include (generally more frequent with sulfasalazine) headache, nausea, abdominal pain, dyspepsia, fatigue, rash, fever, rarely exacerbation of the disease, pancreatitis, pericarditis, pneumonitis, liver disease, nephritis, and bone marrow depression. Watery diarrhea is an adverse effect unique to olsalazine, while anorexia, folate malabsorption, hemolysis, neutropenia, agranulocytosis, male infertility, and neuropathy are unique to sulfasalazine. 

Hepatic parenchymal diseasfii muscle disease Grganophosphorus insecticide oisoningj suxamethonium sensitivity, hepatic parenchymal diseases Muscle diseases, myocardial infarction Hepatic parenchymal diseases Hepatobiliary diseases Hemolysis, hepatic parenchymal diseases, myocardial infarction Pancreatic diseases Hepatobiliary disease Pancreatic diseases... 

Methyldopa can cause hemolytic anemia. At least 20% of patients who receive methyldopa for a year develop a positive Coombs test due to autoantibodies directed against the Rh antigen on erythrocytes. This does not necessitate drug discontinuation 1—5% of these patients will develop a hemolytic anemia that mandates prompt drug discontinuation. The Coombs test may remain positive for as long as a year cffter discontinuation of methyldopa, but the hemolytic anemia usually resolves within a matter of weeks. Severe hemolysis may be attenuated by treatment with glucocorticoids. Rarer adverse effects include leukopenia, thrombocytopenia, red cell aplasia, lupus erythematosus—like syndrome, lichenoid and granulomatous skin eruptions, myocarditis, retroperitoneal fibrosis, pancreatitis, diarrhea, and malabsorption. 

Vitamin E protects the heart and arteries and cellular components from being oxidized and prevents red blood cells from hemolysis (mpture). If there is a sufficient balance of salts, pancreatic secretion, and fat. Vitamin E is absorbed from the GI tract and stored in all tissues, especially in the liver, muscle, and fatty tissues. Seventy-five percent of excess Vitamin E is excreted in the bile and the remainder is excreted in urine. 

---